UnknownPhase 2NCT00021385

Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer

Studying Gonadal germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jonsson Comprehensive Cancer Center
Principal Investigator
Linnea Chap, MD
Jonsson Comprehensive Cancer Center
Intervention
carboplatin(drug)
Eligibility
18 years · FEMALE
Timeline
2001

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00021385 on ClinicalTrials.gov

Other trials for Gonadal germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Gonadal germ cell tumor →

← Back to all trials